Statement of Changes in Beneficial Ownership (Form 4)

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * Coric Vlad 2. Issuer Name and Ticker or Trading Symbol Veradermics, Inc [MANE] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) C/O VERADERMICS, INCORPORATED, 470 JAMES ST. 3. Date of Earliest Transaction (Month/Day/Year) 02/03/2026 (Street) NEW HAVEN, CT 06513 4. If Amendment, Date Original Filed (Month/Day/Year) 6. Individual or Joint/Group Filing (Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 02/05/2026 C(1) 33,706 A (1) 33,706 I See Footnote(2) Common Stock 02/05/2026 C(1) 33,706 A (1) 33,706 I See Footnote(3) Common Stock 02/05/2026 C(4) 148,794 A (4) 182,500 I See Footnote(2) Common Stock 02/05/2026 C(4) 148,794 A (4) 182,500 I See Footnote(3) Common Stock 02/05/2026 C(5) 78,075 A (5) 260,575 I See Footnote(2) Common Stock 02/05/2026 C(5) 78,075 A (5) 260,575 I See Footnote(3) Common Stock 02/05/2026 C(5) 117,112 A (5) 129,939 D Common Stock 02/05/2026 P 58,823 A $17 319,398 I See Footnote(2) Common Stock 02/05/2026 P 58,823 A $17 319,398 I See Footnote(3)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Underlying Securities (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Series A Convertible Preferred Stock	(1)	02/05/2026		C			33,706	(1)	(1)	Common Stock	33,706	(1)	0	I	See Footnote(2)
Series A Convertible Preferred Stock	(1)	02/05/2026		C			33,706	(1)	(1)	Common Stock	33,706	(1)	0	I	See Footnote(3)
Series B Convertible Preferred Stock	(4)	02/05/2026		C			148,794	(4)	(4)	Common Stock	148,794	(4)	0	I	See Footnote(2)
Series B Convertible Preferred Stock	(4)	02/05/2026		C			148,794	(4)	(4)	Common Stock	148,794	(4)	0	I	See Footnote(3)
Series C Convertible Preferred Stock	(5)	02/05/2026		C			78,075	(5)	(5)	Common Stock	78,075	(5)	0	I	See Footnote(2)
Series C Convertible Preferred Stock	(5)	02/05/2026		C			78,075	(5)	(5)	Common Stock	78,075	(5)	0	I	See Footnote(3)
Series C Convertible Preferred Stock	(5)	02/05/2026		C			117,112	(5)	(5)	Common Stock	117,112	(5)	0	D
Stock Option (Right to Buy)	$17	02/03/2026		A		51,525		(6)	02/03/2036	Common Stock	51,525	$ 0	51,525	D

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Coric Vlad C/O VERADERMICS, INCORPORATED 470 JAMES ST. NEW HAVEN, CT 06513	X

Signatures

/s/ Michael Greco, Attorney-in-Fact		02/05/2026
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	On February 5, 2026, the shares of Series A Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.00001 per share ("Common Stock"), on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date.
(2)	Shares held by Vladimir Coric Family Trust 2013.
(3)	Shares held by Vladimir Coric Marital Trust 2013.
(4)	On February 5, 2026, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date.
(5)	On February 5, 2026, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date.
(6)	This option shall be fully vested and exercisable on February 3, 2027, the first anniversary of the vesting commencement date.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.